OR WAIT null SECS
March 02, 2010
Pre-Interphex 2010 Product Releases.
To best carry out the vision of Hatch-Waxman, Congress must act now on biogenerics.
Brief pharmaceutical news items for March 2010.
From last-minute product inserts to putting out fires, close calls are a common occurrence.
If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.
March 01, 2010
A new kind of gastro-retentive dosage form for drugs with poor aqueous solubility was developed and evaluated, with the aim of achieving gastro-retention.
February 25, 2010
Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.
February 18, 2010
RUSNANO, a corporation established by the Russian government to foster the development of nanotechnology, launched a project last week to manufacture targeted-delivery nanodrugs to treat malignant neoplasms.
Abbott Completes Acquisition Of Solvay; Merck Names President of Consumer Healthcare; And More.
February 11, 2010
VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.